Zobrazeno 1 - 9
of 9
pro vyhledávání: '"Yujirou Naganuma"'
Publikováno v:
International Journal of Angiology. 15:12-15
It is known that carbon dioxide causes vasodilatation. Therefore, immersing the extremities into carbonated water would be expected to increase skin blood flow, given that carbon dioxide can permeate through the skin surface. We immersed the ischemic
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::b00954b2a4e7048068966b3b3499678c
https://doi.org/10.1007/s00547-006-2063-0
https://doi.org/10.1007/s00547-006-2063-0
Publikováno v:
Internal Medicine. 50:381-387
Objective The association between carotid atherosclerosis and the metabolic syndrome (MetS) was analyzed in the general population. The usefulness of the inclusion of the serum adiponectin concentration in the MetS criteria for the detection of ather
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::75a1c598f07549a6ca91443a3853c94d
https://doi.org/10.2169/internalmedicine.50.4476
https://doi.org/10.2169/internalmedicine.50.4476
Publikováno v:
Atherosclerosis. 213:306-310
Patients with chronic kidney disease (CKD) show a much higher risk of cardiovascular disease. However, the mechanisms underlying this association and the impact of CKD on behaviors of the vascular walls have not been fully clarified. Using ultrasonog
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8f4205980ab3c6ef88159f0359083caf
https://doi.org/10.1016/j.atherosclerosis.2010.08.057
https://doi.org/10.1016/j.atherosclerosis.2010.08.057
Autor:
Motoyuki Nakamura, Akihiko Abiko, Shinji Makita, Makiko Tamada, Mizuyoshi Nagai, Yujirou Naganuma
Publikováno v:
Metabolism. 59:653-657
A higher ratio of low-density lipoprotein cholesterol (LDL-C) to high-density lipoprotein cholesterol (HDL-C) is associated with a greater risk of cardiovascular events in patients with coronary heart disease. However, the role of this lipid index du
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::48654f9b0adbd532906582d6fd8a9f8c
https://doi.org/10.1016/j.metabol.2009.09.009
https://doi.org/10.1016/j.metabol.2009.09.009
Autor:
Hiroki Matsui, Makiko Tamada, Shinji Makita, Motoyuki Nakamura, Yujirou Naganuma, Akihiko Abiko
Publikováno v:
Atherosclerosis. 208:167-170
Background Increased arterial stiffness is associated with greater risk of cardiovascular events and mortality. However, in patients with peripheral arterial disease (PAD) who have severe atherosclerotic disorder or risk clustering, the major determi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3c0ba5461088b5c39b0e3bd38bd7a208
https://doi.org/10.1016/j.atherosclerosis.2009.06.033
https://doi.org/10.1016/j.atherosclerosis.2009.06.033
Publikováno v:
Clinical and experimental hypertension (New York, N.Y. : 1993). 31(2)
Hypertensive patients whose BP was uncontrolled despite the use of antihypertensive agents, including an ARB (candesartan 8 mg/day or valsartan 80 mg/day), were enrolled. The patients were randomly assigned to combination therapy with telmisartan 40
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::023a81fb7caab2043d8475fe9b398998
https://pubmed.ncbi.nlm.nih.gov/19330600
https://pubmed.ncbi.nlm.nih.gov/19330600
Publikováno v:
Metabolism: clinical and experimental. 57(10)
Few studies have analyzed intraclass differences in angiotensin II receptor blockers (ARBs) with respect to antidiabetic or metabolic effects. We designed a prospective randomized study to compare a peroxisome proliferator-activated receptor-gamma (P
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f95daf959669feef7ba07a63d816b35d
https://pubmed.ncbi.nlm.nih.gov/18803955
https://pubmed.ncbi.nlm.nih.gov/18803955
Publikováno v:
Cardiovascular Drugs and Therapy. 21:317-318
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::fe6b0fd4d0e408e96e1be74710d9969f
https://doi.org/10.1007/s10557-007-6039-x
https://doi.org/10.1007/s10557-007-6039-x
Publikováno v:
Cardiovascular Drugs & Therapy; Aug2007, Vol. 21 Issue 4, p317-318, 2p